KLHL7
protein-codingkelch like family member 7, the group of Kelch like|BTB domain containing
Gene summary
This gene encodes a BTB-Kelch-related protein. The encoded protein may be involved in protein degradation. Mutations in this gene have been associated with retinitis pigmentosa 42. [provided by RefSeq, Feb 2010]
MANE transcript
Inheritance
ClinVar variants
Top phenotype
gnomAD constraint
Max pathogenic AF
Genomic locus
External References & Databases
Transcript & Mutation Effects
hg38 • Region Span ~72.2 kbGenCC Phenotypes & Disease Associations
Curated gene-disease validity assertions and inheritance patterns
Inheritance Pattern: AD
Disease ID:MONDO:0019200
Submitter: Orphanet
Inheritance Pattern: AR
Disease ID:MONDO:0015526
Submitter: Orphanet
Inheritance Pattern: AD
Disease ID:MONDO:0013052
Submitter: Labcorp Genetics (formerly Invitae)
Inheritance Pattern: AD
Disease ID:MONDO:0013052
Submitter: G2P
Inheritance Pattern: AD
Disease ID:MONDO:0013052
Submitter: PanelApp Australia
Inheritance Pattern: AR
Disease ID:MONDO:0014890
Submitter: PanelApp Australia
Inheritance Pattern: AD
Disease ID:MONDO:0013052
Submitter: Ambry Genetics
Inheritance Pattern: AR
Disease ID:MONDO:0014890
Submitter: Ambry Genetics
Inheritance Pattern: AR
Disease ID:MONDO:0014890
Submitter: Illumina
Inheritance Pattern: AR
Disease ID:MONDO:0014890
Submitter: G2P
Clinical Genomic Database (CGD)
Manifestation: Musculoskeletal; Neurologic; Ophthalmologic
Intervention: Musculoskeletal
Rationale: In the neonatal/early childhood period, the condition can be lethal unless advanced care is instituted; Later, it has been described that cold-induced sweating was alleviated by medical treatment (eg, with clonidine)
ClinVar Associated Diseases & Phenotypes
Reported disease conditions connected to KLHL7 variants in ClinVar
ClinVar Variants & Pathogenicity by Type
Statistics based on transcript NM_001031710.3. Only rare variants are included.
We include only reliable ClinVar variants with their consequences to MANE Select, MANE Plus Clinical transcripts, or transcripts with TSL equal to 1. Click a count to filter the variants table below.
Slight differences between displayed counts and ClinVar may occur due to a different transcript/consequence chosen by our variant effect predictor, or because we classify Benign/Likely benign as Likely benign and Pathogenic/Likely pathogenic as Likely pathogenic.
| Effect | PathogenicP | Likely pathogenicLP | VUS | Likely benignLB | BenignB | Sum |
|---|---|---|---|---|---|---|
| synonymous | 5 | 122 | 2 | 129 | ||
| missense | 4 | 11 | 177 | 2 | 194 | |
| nonsense | 8 | 2 | 4 | 14 | ||
| start loss | 0 | |||||
| frameshift | 11 | 8 | 1 | 20 | ||
| splice donor/acceptor (+/-2bp) | 8 | 2 | 10 | |||
| Total | 23 | 29 | 189 | 124 | 2 | 367 |
Highest pathogenic variant AF is 0.000025433297
Transcript Catalog
Annotated transcript isoforms across RefSeq and Ensembl databases
| Transcript ID | Source | Protein ID | Coding Exons | MANE Status |
|---|---|---|---|---|
| RefSeq | NP_001026880.2 | 11 | MANE Select | |
| Ensembl | ENSP00000343273.4 | 11 | MANE Select | |
| RefSeq | NP_001165899.1 | 5 | Standard | |
| RefSeq | NP_061334.4 | 10 | Standard |
Gene Ontology (GO) Annotations & Pathways
Biological processes, molecular functions, cellular components and pathways
Biological Process
- protein ubiquitination
Molecular Function
- protein binding
- identical protein binding
- protein homodimerization activity
Cellular Component
- nucleus
- nucleoplasm
- nucleolus
- cytosol
- plasma membrane
gnomAD Constraint
Source:
- Gene type
- protein_coding
- Transcript type
- protein_coding
- Transcript
- ENST00000339077
- Coding exons
- 11
- Length
- 72181
- Individuals with no LoFs
- 125713
- Homozygous LoFs
- 0
- Heterozygous LoFs
- 35
- Defined
- 125748
- p
- 0.000139
| Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible | |
|---|---|---|---|---|---|---|
| Missense | 3.91 | 123 | 320 | 0.385 | 0.0000166 | 3872 |
| Missense (PolyPhen) | 29 | 87.734 | 0.33054 | 998 | ||
| Synonymous | 0.837 | 101 | 112 | 0.899 | 0.00000620 | 1089 |
| Loss of Function | 3.13 | 13 | 32.1 | 0.404 | 0.00000196 | 357 |
Population LoF Frequency
| Population | CAF | p-value | Status |
|---|---|---|---|
| African | 0.00018 | 0.00018 | rare |
| Latino/Admixed American | 0.00014 | 0.00014 | rare |
| Ashkenazi Jewish | 0.000099 | 0.000099 | rare |
| East Asian | 0.000054 | 0.000054 | rare |
| Finnish | 0.00028 | 0.00028 | rare |
| European (Non-Finnish) | 0.00014 | 0.00014 | rare |
| South Asian | 0.000098 | 0.000098 | rare |
| Other | 0 | 0.0 | absent |
dbNSFP Gene Annotations
Source:
- Function
- FUNCTION: Substrate-specific adapter of a BCR (BTB-CUL3-RBX1) E3 ubiquitin ligase complex. The BCR(KLHL7) complex acts by mediating ubiquitination and subsequent degradation of substrate proteins. Probably mediates 'Lys-48'-linked ubiquitination. {ECO:0000269|PubMed:21828050}.;
- Disease
- DISEASE: Retinitis pigmentosa 42 (RP42) [MIM:612943]: A retinal dystrophy belonging to the group of pigmentary retinopathies. Retinitis pigmentosa is characterized by retinal pigment deposits visible on fundus examination and primary loss of rod photoreceptor cells followed by secondary loss of cone photoreceptors. Patients typically have night vision blindness and loss of midperipheral visual field. As their condition progresses, they lose their far peripheral visual field and eventually central vision as well. {ECO:0000269|PubMed:19520207, ECO:0000269|PubMed:20547956, ECO:0000269|PubMed:21828050, ECO:0000269|PubMed:22084217}. Note=The disease is caused by mutations affecting the gene represented in this entry.;
Recessive Scores
- pRec
- 0.122
Intolerance Scores
- LoFtool
- 0.646
- RVIS EVS
- -0.76
- RVIS percentile EVS
- 13.33
Essentials
- Essential (CRISPR)
- N
- Essential (CRISPR2)
- S
- Essential (gene trap)
- N
- Indispensability pred.
- N
- Indispensability score
- 0.296
Gene Damage Prediction
| All | Recessive | Dominant | |
|---|---|---|---|
| Mendelian | Medium | Medium | Medium |
| Primary Immunodeficiency | Medium | Medium | Medium |
| Cancer | Medium | Medium | Medium |